Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02214667 · ClinicalTrials.gov registry record · NA

Treating Co-Occurring Substance Use and Mental Disorders Among Jail Inmates

A NA study, sponsored by RTI International.

Terminated
Registry status
NA
Development phase
8
Enrollment target

NCT02214667: Clinical Trial NA study, sponsored by RTI International.

NCT02214667 is a NA study that was terminated before completion, run by RTI International. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02214667, a NA study, was terminated before completion, sponsored by RTI International.

TERMINATED
Registry status
NA
Development phase
8 participants
Enrollment target

Study Summary

Treatment adaptation and implementation study for adult jail inmates with co-occurring substance use disorders.

Primary Outcome

Client Satisfaction Questionnaire-8, Narrative Evaluation of Intervention Interview

Interventions

  • BEHAVIORAL Dual-diagnosis motivational interviewing (DDMI)
  • BEHAVIORAL Integrated group therapy (IGT)
  • BEHAVIORAL Jail and community-based behavioral health services

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2015-05-21
Est. Completion 2019-06-30
Phase NA
RTI International

45 total trials

Why NCT02214667 stopped before completion

NCT02214667 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 3 interventions - of which Dual-diagnosis motivational interviewing (DDMI) is the first listed.

NCT02214667 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02214667 about?

NCT02214667 is a clinical study titled "Treating Co-Occurring Substance Use and Mental Disorders Among Jail Inmates". Treatment adaptation and implementation study for adult jail inmates with co-occurring substance use disorders.

What is the current status of trial NCT02214667?

This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2015-05-21. Estimated completion is 2019-06-30.

What interventions are being tested in trial NCT02214667?

The interventions under investigation include: Dual-diagnosis motivational interviewing (DDMI) (BEHAVIORAL), Integrated group therapy (IGT) (BEHAVIORAL), Jail and community-based behavioral health services (BEHAVIORAL).

Who is sponsoring clinical trial NCT02214667?

This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02214667's enrollment target sits among peer trials

8 1976th of 2000 higher than 19 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02214667, the US trial registry maintained by the National Library of Medicine. NCT02214667 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.